Skip to main content
David Sprecher

David Sprecher

David Shprecher, DO, MSci, FAAN, is a movement disorders neurologist and senior movement disorders director at Banner Sun Health Research Institute (Banner Health), specializing in Parkinson's disease.

Sep 28, 2026

8:39
Okay.
8:41
But now we're in what I call the post-crexant world.
8:45
So crexant's in a class of its own, even though it's carbidopa levodopa.
8:52
Not only does it have a time release component to about 70% of the little beads inside.
9:00
But because it has this adhesive sticky coating, it stays at the top of your intestine until it's fully absorbed.
9:08
So if you, as you alluded to, if you're used to just having, you know, three doses five hours apart and then maybe a slightly lower one at bedtime, but instead you're doing that around the clock, you could potentially get in a situation where you're absorbing more than you're used to in a 24-hour period.
9:27
Mm-hmm.

6 MINS LATER

15:03
Right.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.